Abstracts
Background and Aims
The detailed risk factors such as bleeding pattern, comorbidities, and medication usage of patients with obscure gastrointestinal bleeding (OGIB) are largely unknown. We evaluated the risk factors related to ulcerative and vascular lesions of the small intestine diagnosed by capsule endoscopy or balloon-assisted endoscopy in OGIB cases.
Methods
We retrospectively evaluated 390 OGIB cases (occult, n = 101; overt, n = 289) in our hospital between January 2005 and March 2011 using univariate and multivariate logistic regression analyses to determine the related risk factors.
Results
In occult (n = 36) and overt (n = 120) OGIB cases, some lesions were detected in the small intestine. Ulcerative and vascular lesions were detected in both occult (n = 25, 69.4 %; n = 8, 22.2 %, respectively) and overt (n = 57, 47.5 %; n = 39, 32.5 %, respectively) cases. For ulcerative lesions, non-steroidal anti-inflammatory drugs were identified as a risk factor in overt cases [odds ratio (OR) 2.974, 95 % confidence interval (CI) 1.522–5.809, P = 0.001]. For vascular lesions, lowest hemoglobin level (OR 0.634, 95 % CI 0.422–0.953, P = 0.028) and hematologic disease (OR 8.575, 95 % CI 1.076–68.309, P = 0.042) were identified as risk factors in occult cases, whereas hemodialysis (OR 3.71, 95 % CI 1.315–10.467, P = 0.013) was identified in overt cases. Additionally, liver cirrhosis was noted as a risk factor in both occult (OR 7.453, 95 % CI 1.213–45.773, P = 0.013) and overt (OR 4.900, 95 % CI 2.099–11.443, P < 0.001) OGIB cases.
Conclusion
There are differences in risk factors related to ulcerative versus vascular lesions in the small intestine in occult and overt OGIB cases. Differences were seen in both medication usage and comorbidities.
Similar content being viewed by others
References
Rockey DC. Occult gastrointestinal bleeding. N Engl J Med. 1999;341:38–46.
Matsumoto T, Moriyama T, Esaki M, et al. Performance of antegrade double-balloon enteroscopy: comparison with push enteroscopy. Gastrointest Endosc. 2005;62:392–398.
Mylonaki M, Fritscher-Ravens A, Swain P. Wireless capsule endoscopy: a comparison with push enteroscopy with gastroscopy and colonoscopy negative gastrointestinal bleeding. Gut. 2003;52:1122–1126.
Saurin JC, Delvaux M, Gaudin JL, et al. Diagnostic values of endoscopic capsule in patients with obscure bleeding: blinded comparison with video push enteroscopy. Endoscopy. 2003;35:576–584.
Constamagna G, Shah SK, Riccioni ME, et al. A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease. Gastroenterology. 2002;123:999–1005.
Saperas E, Dot J, Videla S, et al. Capsule endoscopy versus computed tomography or standard angiography for the diagnosis of obscure gastrointestinal bleeding. Am J Gastroenterol. 2007;102:731–737.
Teshima CW, Kuipers EJ, van Zanten SV, et al. Double balloon enteroscopy and capsule endoscopy for obscure gastrointestinal bleeding: an updated meta-analysis. J Gastroenterol Hepatol. 2011;26:796–801.
Nakamura M, Niwa Y, Ohmiya N. Preliminary comparison of capsule endoscopy and double-balloon enteroscopy in patients with suspected small-bowel bleeding. Endoscopy. 2006;38:59–66.
Carey EJ, Leighton JA, Heigh RI, et al. A single-center experience of 260 consecutive patients undergoing capsule endoscopy for obscure gastrointestinal bleeding. Am J Gastroenterol. 2007;102:89–95.
Goenka MK, Majumder S, Kumar S, et al. Single center experience of capsule endoscopy in patients with obscure gastrointestinal bleeding. World J Gastroenterol. 2011;17:774–778.
Nakayama S, Tominaga K, Obayashi T, et al. The prevalence of adverse events associated with double-balloon enteroscopy from a single-centre dataset in Japan. Dig Liver Dis. 2014;46:706–709.
Pennazio M, Santucci R, Rondonotti E, et al. Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: report of 100 consecutive cases. Gastroenterology. 2004;126:643–653.
Selby W. Can clinical features predict the likelihood of finding abnormalities when using capsule endoscopy in patients with GI bleeding of obscure origin? Gastrointest Endosc. 2004;59:782–787.
Redondo-Cerezo E, Perez-Vigara G, Perez-Sola A, et al. Diagnostic yield and impact of capsule endoscopy on management of patients with gastrointestinal bleeding of obscure origin. Dig Dis Sci. 2007;52:1376–1381.
Sidhu R, Sanders DS, Kapur K, et al. Factors predicting the diagnostic yield and intervention in obscure gastrointestinal bleeding investigated using capsule endoscopy. J Gastrointest Liver Dis. 2009;18:273–278.
Lepileur L, Dray X, Antonietti M, et al. Factors associated with diagnosis of obscure gastrointestinal bleeding by video capsule enteroscopy. Clin Gastroenterol Hepatol. 2012;10:1376–1380.
Shahidi NC, Ou G, Svarta S, et al. Factors associated with positive findings from capsule endoscopy in patients with obscure gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2012;10:1381–1385.
Sakai E, Endo H, Taniguchi L, et al. Factors predicting the presence of small bowel lesions in patients with obscure gastrointestinal bleeding. Dig Endosc. 2013;25:412–420.
Cúrdia Gonçalves T, Magalhães J, Boal Carvalho P. Is it possible to predict the presence of intestinal angioectasias? Diagn Ther Endosc. 2014;461602:1–6.
Goldstein JL, Eisen GM, Lewis B, et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol. 2005;3:133–141.
Maiden L, Thjodleifsson B, Theodors A, et al. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology. 2005;128:1172–1178.
Graham DY, Opekun AR, Willingham FF, et al. Visible small-bowel intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005;3:55–59.
Watanabe T, Sugimori S, Kameda N, et al. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol. 2008;11:1279–1282.
Watanabe T, Takeuchi T, Handa O, et al. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage. PLoS One. 2015;10:e0122330.
Ohmori T, Konishi H, Nakamura S, et al. Abnormalities of the small intestine detected by capsule endoscopy in hemodialysis patients. Intern Med. 2012;51:1455–1460.
Sugano K, Marcon N. The first international workshop on double balloon endoscopy: a consensus meeting report. Gastrointest Endosc. 2007;66:7–11.
Xin L, Liao Z, Jiang YP, et al. Indications, detectability, positive findings, total enteroscopy, and complications of diagnostic double-balloon endoscopy: a systematic review of data over the first decade of use. Gastrointest Endosc. 2011;74:563–570.
Richardson JD, Lordon RE. Gastrointestinal bleeding caused by angiodysplasia: a difficult problem in patients with chronic renal failure receiving hemodialysis therapy. Am Surg. 1993;59:636–638.
De Palma GD, Rega M, Masone S, et al. Mucosal abnormalities of the small bowel in patients with cirrhosis and portal hypertension: a capsule endoscopy study. Gastrointest Endosc. 2005;62:529–534.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Tetsuo Arakawa has participated in advisory committees for Otsuka Pharmaceutical Co. Ltd. and Eisai Co. Ltd. Yasuhiro Fujiwara has participated in advisory committees for Eisai Co. Ltd. All other authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Okamoto, J., Tominaga, K., Sugimori, S. et al. Comparison of Risk Factors Between Small Intestinal Ulcerative and Vascular Lesions in Occult Versus Overt Obscure Gastrointestinal Bleeding. Dig Dis Sci 61, 533–541 (2016). https://doi.org/10.1007/s10620-015-3904-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-015-3904-5